Feasibility Study of Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease

Launched by ASCENTYS LTD · Sep 19, 2023

Keywords

ClinConnect Summary

This clinical trial is testing a computer game called G:DATA, which is designed to help diagnose Alzheimer's Disease and mild cognitive impairment. The study will involve different groups of people, including some who already have Alzheimer's. The researchers want to see if the results from playing G:DATA match those from current tests used to diagnose the disease. They will also gather feedback from patients and healthcare staff about their experiences with the game.

To be eligible for this study, participants should be aged between 55 and 79 years and be willing to provide informed consent, which means they understand the study and agree to take part. However, people with certain conditions like epilepsy, severe visual impairments, or a history of significant head injuries won't be able to participate. The trial is not recruiting participants yet, but when it does, those who join can expect to play the game and share their thoughts about it, helping researchers learn more about how technology can assist in early diagnosis of Alzheimer's Disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged between 55-79 years
• • Willing and able to provide informed consen-
• Exclusion Criteria:
• • A concurrent diagnosis of epilepsy
• • A history of severe visual impairment, e.g. macular degeneration, diabetic reti-nopathy, as determined by the clinical team
• • A history of head trauma
• • Presence of Sleep Apnoea
• • History of alcohol dependence
• • History of illicit drug use
• • Severe upper limb arthropathy
• • The use of cognitive enhancing drugs e.g. cholinesterase inhibitors-